Patents
Patents for C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
03/2010
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/24/2010EP1839662B1 Antitumor agent
03/24/2010EP1615699B1 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
03/24/2010CN101679290A 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
03/23/2010US7683201 cost efficiency; environmentally friendly
03/23/2010US7683053 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
03/18/2010US20100069628 Multidentate AZA Ligands Able to Complex Metal Ions And The Use Thereof In Diagnostics And Therapy
03/18/2010US20100069373 Substituted lactams as inhibitors of a beta protein production
03/18/2010US20100069370 Compounds, compositions and methods
03/18/2010US20100069369 Kinase Inhibitors And Their Uses
03/18/2010US20100069368 Organic Compounds and Their Uses
03/18/2010US20100069367 LXR and FXR Modulators
03/18/2010US20100069366 Antibacterial quinoline derivatives
03/18/2010US20100069365 Diazepane-acetamide derivatives as selective 11B-HSD1 inhibitors
03/18/2010US20100069354 7-azaindole derivatives and their use in the inhibition of c-jun n-terminal kinase
03/17/2010EP2163538A1 Preparation methods of 4-acetyl-2,3,4,5-tetrahydro- benzo[1,4]diazepine and their intermediates
03/16/2010US7678785 Fungicides; (E)-N-[2-((S)-3-Aminopyrrolidin-1-yl)-2-oxo-ethyl]-3-phenyl-N-(3'-trifluoromethoxy-biphenyl-4-yl)-acrylamide; inhibitors of beta -1,3-glucan synthase; readily synthesised by standard chemistry, and have more drug-like properties that are compatible with oral bioavailability
03/16/2010CA2386980C Benzodiazepine derivatives for use in acute or chronic neurological disorders
03/11/2010WO2010026989A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide
03/10/2010CN100593539C Malonamide derivatives blocking the activtiy of gamma-secretase
03/09/2010US7674899 Dimeric azacyclic compounds and their use
03/09/2010US7674797 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders
03/04/2010US20100056501 Substituted lactams as inhibitors of abeta protein production
02/2010
02/25/2010WO2004092124A8 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
02/25/2010US20100048541 Substituted lactams as inhibitors of abeta protein production
02/25/2010US20100048540 Heterocyclic N-Oxides as Hypoxic Selective Protein Kinase Inhibitors
02/24/2010EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use
02/24/2010CN101657432A Dihydro-benzo[B][1,4]diazepin-2-one sulfonamide derivatives
02/23/2010CA2345146C Cyanophenyl derivative
02/18/2010US20100041639 Cyclic malonamides as inhibitors of a beta protein production
02/18/2010US20100041637 1,3-Oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11ß-hydroxysteroid dehydrogenase 1
02/17/2010EP2152673A2 3- to 7-membered 1,3-diaza-4-oxo-heterocyclic derivatives capable of releasing active aldehydes or ketones
02/17/2010EP2152080A1 Novel soluble 1,4 benzodiazepine compounds and stable salts thereof
02/16/2010US7662816 Cognition activators; neurodegenerative disorders; Alzheimer's disease
02/11/2010WO2010016554A1 Cyclic amine compound
02/11/2010WO2010015613A1 Organic compounds
02/11/2010US20100035864 2,2-Dimethyl-4-oxo-4-(4-{4-[(2-phenyl-5-trifluoromethyl-oxazole-4-carbonyl)-amino]-phenyl}-[1,4]diazepan-1-yl)-butyric acid, hydrochloride; obesity, type II diabetes mellitus and metabolic syndrome
02/11/2010CA2732932A1 Organic compounds
02/09/2010CA2451240C Cyclic diamine compound with 6 membered ring groups
02/04/2010WO2010012619A1 Diazepan and piperazine derivatives modulators of chemokine receptors
02/04/2010US20100029621 Hexafluoroisopropanol derivatives
02/04/2010CA2730770A1 Diazepan and piperazine derivatives modulators of chemokine receptors
02/02/2010US7655647 3-[(1-oxo-2-cyclopropylmethyl-heptyl)]amino-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one; amyloid precursor protein and beta -peptide inhibitor; beta or gamma secretases inhibitor; amyloid plaques and neurofibrillar tangles; neurodegenerative diseases: Alzheimer's disease; Down syndrome
02/02/2010US7655646 Antineoplastic agents
01/2010
01/28/2010WO2009145357A8 Benzo [1, 4] diazepines substituted at the 1-position by a ring, for use as antidepressants
01/28/2010US20100022518 Novel heterocyclyl compounds
01/21/2010WO2010006938A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
01/21/2010WO2010006792A1 Synthesis of cyclic amidines
01/21/2010US20100016279 Bicyclic derivatives for use in the treatment of androgen receptor associated conditions-155
01/21/2010US20100015063 Benzodiazepine Derivatives and Pharmaceutical Compositions Containing Them
01/21/2010CA2730056A1 Novel heterocyclyl compounds for treatment of cardiovascular disease
01/20/2010CN101628897A Method for preparing 2,3-dihydro-1H-1,4-benzodiazepine compounds
01/19/2010US7649015 Saquinavir-like, a Lopinavir-like, a Ritonavir-like, a Indinavir-lik, a atazanavir-like, Nelfinavir-like.a Tipranavir-like, a Amprenavir-like, a KNI-like. a cyclic carbonyl-like phosphonate HIV protease inhibitors; drug designing
01/19/2010CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors
01/19/2010CA2239904C Inhibitors of interleukin-1.beta. converting enzyme
01/14/2010US20100009966 Substituted lactams as inhibitors of abeta protein production
01/14/2010US20100009965 Cyclic malonamides as inhibitors of abeta protein production
01/13/2010CN100579957C Novel arylamidine derivative or salt thereof
01/12/2010US7645775 N3-[4-(4-Morpholin-4-yl-cyclohexyl)-phenyl]-1-pyridin-2-yl-1H-[1,2,4]triazole-3,5-diamine; antiproliferative agent; Alzheimer's Disease; Multiple Sclerosis Parkinson's Disease, asthma, schizophrenia, anti-nflammatory agent; cardiovascular disease; bone disorders
01/12/2010US7645764 Kinase inhibitors and methods for using the same
01/12/2010CA2192089C Inhibitors of interleukin-1.beta. converting enzyme
01/07/2010US20100004227 Compositions and methods relating to novel compounds and targets thereof
01/07/2010US20100004226 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
01/07/2010US20100003260 Phenylpentadienoyl derivatives and their use as par 1 antagonists
01/06/2010EP2139331A1 Compositions and methods relating to novel compounds and targets thereof
01/06/2010CN100577651C Lactam compound and medicinal use thereof
12/2009
12/31/2009US20090325939 1h-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof
12/30/2009WO2009156776A1 Process for the preparation of high purity 1-(3,4-dimethoxy-phenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5h-2,3-benzodiazepine
12/30/2009WO2009156678A2 Fumarate salt of 4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate, crystalline forms thereof, preparation thereof and therapeutic use thereof
12/30/2009EP2138482A1 Bicyclic heterocyclic compound
12/30/2009EP2137167A1 Dihydro-benzo[b][1,4]diazepin-2-one sulfonamide derivatives
12/29/2009US7638624 Antiinflammatory agents; autoimmune diseases; antiproliferative agents; using benzodiazepine compound
12/24/2009US20090318427 Benzodiazepine derivatives for treating hepatitis c infection
12/24/2009US20090317842 Methods and Tools for The Therapy of Neurodegenerative Pathologies
12/22/2009CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009CA2307879C Treatment of t-helper cell type 2 mediated immune diseases
12/15/2009US7632830 Lactam compounds and pharmaceutical use thereof
12/15/2009US7632829 Diazepan derivatives
12/09/2009EP2130534A1 Use of ritonavir for improving the pharmacokinetics of drugs metabolized by cytochrome P450
12/09/2009CN101600698A Quinazolinone and isoquinolinone acetamide derivatives
12/09/2009CN100567279C Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors
12/08/2009CA2485916C Non-nucleoside reverse transcriptase inhibitors
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/03/2009WO2009145357A1 In 1-position durch einen ring substituierte benzo [1, 4] diazepine zur verwendungs als antidepressiva
12/03/2009WO2009145219A1 Therapeutic agent for alzheimer's disease
12/03/2009CA2729812A1 Therapeutic agent for alzheimer's disease
12/02/2009EP2125750A2 Cyclic urea and carbamate inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/01/2009US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/01/2009US7625886 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions
11/2009
11/25/2009EP2121619A2 Compounds for the treatment of diseases associated with amyloid or amyloid-like proteins
11/24/2009US7622467 Aryl aniline derivatives as β2 adrenergic receptor agonists
11/19/2009WO2009139168A1 Therapeutic agent for pain
11/19/2009WO2009138438A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives
11/19/2009US20090286771 2-Phenoxy- and 2-Phenylsulfonamide Derivatives with CCR3 Antagonistic Activity for the Treatment of Inflammatory or Immunological Disorders
11/19/2009US20090285849 Thiosemicarbazones as anti-virals and immunopotentiators
11/19/2009CA2723826A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperazine derivatives
11/19/2009CA2723623A1 Therapeutic agent for pain
11/18/2009EP2119476A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/18/2009EP1421071B1 Substituted piperazine and diazepane derivaives as histamine h3 receptor modulators
11/17/2009US7618958 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... 60